drugset / Trial / NCT03531697
Study of Loteprednol Etabonate in Adults Undergoing Bilateral Cataract Surgery
RandomizedCrossoverSingle-blindOther
Summary
This study will assess the bioequivalence of Loteprednol Etabonate and the reference listed drug (RLD)
Timeline
- Start
- 2018-04-26
- Primary completion
- 2019-09-07
- Completion
- 2019-10-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Loteprednol Etabonate | Other / unclassified | — | — |
Indications
No indication recorded.